疝气修补器材市场 - 全球产业规模、份额、趋势、机会、预测：按产品类型、手术类型、手术方式、地区和竞争格局划分，2021-2031年

全球疝气修復器材市场预计将从 2025 年的 64.5 亿美元成长到 2031 年的 77.8 亿美元，复合年增长率为 3.17%。

这些装置包括用于疝气修补手术中重建或加强组织壁的专用外科网片和固定係统。该领域的发展主要受人口老化和肥胖率上升的驱动，这两者都会增加腹壁缺损的生理易感性。此外，微创腹腔镜手术和机器人辅助手术的持续发展也加速了对先进生物材料和合成修復材料的需求。

然而，对术后併发症和与合成网片植入相关的诉讼的持续审查，正为市场扩张带来阻力。这可能会延迟监管核准，并影响临床应用。儘管存在这些监管挑战，但现有医疗体系内的手术数量仍居高不下，确保了对修復器械的稳定需求。例如，英国英国外科医学院报告称，疝气修补术仍将是2024年最常见的外科手术之一，英国每年将进行超过12万例手术。

市场驱动因素

机器人和腹腔镜手术平台的技术进步正在改变市场格局，显着提升手术精准度并加快患者康復速度。微创技术的这一趋势在一般外科手术数量的增长中尤为明显，机器人系统已成为复杂腹壁重组的标准配置。根据直觉外科公司（Intuitive Surgical）截至2025年1月的初步数据，2024年全球达文西手术量预计将成长约17%，这一成长主要得益于美国一般外科手术的应用。这项技术的应用正在推动大量手术的开展，TELA Bio指出，到2025年，美国每年将进行约150万例疝气修补手术，继续保持其作为主要手术项目之一的地位。

同时，随着外科医生努力减少与永久性合成植入相关的慢性发炎反应，生物材料和可吸收生物网状材料的创新正在推动市场发展。这些先进的基质旨在支持自然组织重塑并最大限度地降低復发风险，从而满足高风险患者群体的关键需求。这些混合支架的商业性成功凸显了材料领域向能够保留解剖结构的重大转变。根据 Fierce Biotech 于 2025 年 12 月报道，TELA Bio 宣布其 2024 年全年销售额为 6,930 万美元（年成长 19%），这一增长归功于对其 OviTex 增强型生物网膜产品线的需求。

市场挑战

对合成网片植入术后併发症的持续监测以及相关的法律纠纷，对全球疝气修补器械市场的准入和扩张构成了重大障碍。製造商必须满足严格的临床证据标准以降低责任风险，这项要求显着增加了研发成本并延长了核准时间。这种严格的法规环境迫使企业将资金用于法律辩护和合规，而非创新，延缓了下一代疝气修补器械的商业化进程。

这些监管压力直接降低了区域市场的吸引力和产品的可及性。根据欧洲医疗技术协会（MedTech Europe）2024年的数据，由于满足更先进的安全性和性能要求的复杂性，选择欧盟作为其首发市场的大型医疗设备製造商比例下降了33%。这一趋势表明，出于安全考虑而製定的更严格的法规实际上限制了进入现有医疗保健系统的新产品数量。随着先进技术的应用受到阻碍，市场正面临收入周转率放缓和新型修復材料在外科手术中应用率下降的双重困境。

市场趋势

疝气修补手术向门诊手术中心（ASC）的转移，从根本上改变了腹壁重组医疗服务的提供方式。保险公司和医疗系统正积极推动成本效益和提高手术周转率，将腹股沟疝气和腹部疝气修復等中等急性手术从医院住院部转移到门诊机构。大型医疗系统专科手术部门的显着收入成长支撑了这个结构性转变。例如，根据ASC News在2025年2月报道，Tenet Healthcare的子公司United Surgical Partners International（USPI）2024年全年净营业收入达45亿美元，较去年同期成长15.4%。这一增长主要得益于高风险病例向门诊机构的转移。

同时，生物来源和生物合成网植入的需求激增，尤其是那些采用先进聚合物技术（例如聚-4-羟基丁酸酯 (P4HB)）的产品。与以往仅限于高风险患者复杂重组手术的生物来源产品不同，新型生物合成平台正进入市场，用于治疗脐疝气等常见缺陷，提供可吸收支架，在不留下永久性异物的情况下提供暂时的支撑力。这种应用得益于新一代可吸收产品组合的商业性扩张。根据 Xtalks 2025 年 4 月报道，贝克顿·迪金森公司推出了一种新型 P4HB 补片，并宣布其生物可吸收 Phasix 网片产品组合的全球植入量已超过 38.5 万例。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球疝气修补器材市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类型（疝气修补网片、疝气固定装置）
  • 透过手术方法（开放性手术、腹腔镜手术）
  • 手术类型（腹股沟疝气、脐疝气、切口疝气、股疝气、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美疝气修补器材市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲疝气修补器材市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区疝气修补器材市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲疝气修补器材市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲疝气修补器材市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球疝气修补器材市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic Plc.
• Ethicon Inc.
• Beckton Dickinson & Co,
• Atrium
• WL Gore & Associates, Inc.
• LifeCell International Pvt. Ltd.
• B. Braun SE
• Baxter International Inc.
• Cook Medical Inc
• Herniamesh Srl

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Hernia Repair Devices Market is projected to expand from USD 6.45 Billion in 2025 to USD 7.78 Billion by 2031, achieving a CAGR of 3.17%. These devices consist of specialized surgical meshes and fixation systems used to reconstruct or reinforce tissue walls during herniorrhaphy procedures. Growth in this sector is primarily fueled by an aging population and rising obesity rates, both of which increase physiological susceptibility to abdominal wall defects. Additionally, the continued transition toward minimally invasive laparoscopic and robotic-assisted surgeries is accelerating the demand for advanced biologic and synthetic repair materials.

However, market expansion faces headwinds due to persistent scrutiny regarding post-operative complications and litigation involving synthetic mesh implants, which can delay regulatory approvals and impact clinical adoption. Despite these regulatory challenges, procedural volumes remain high within established healthcare systems, ensuring a steady demand for repair devices. For instance, the Royal College of Surgeons of England reported that in 2024, hernia repair remained one of the most frequent surgical interventions, with more than 120,000 operations performed annually across the United Kingdom.

Market Driver

Technological progress in robotic and laparoscopic platforms is significantly reshaping the market by facilitating greater precision and faster patient recovery. This trend toward minimally invasive techniques is particularly visible in the rise of general surgery volumes, where robotic systems are increasingly becoming the standard for complex abdominal wall reconstructions. According to Intuitive Surgical's preliminary results from January 2025, worldwide da Vinci procedures increased by approximately 17% in 2024, a growth largely driven by general surgery applications in the United States. This technological adoption supports a substantial procedural workload, with TELA Bio noting in 2025 that hernia repairs remain a leading surgery in the U.S., accounting for roughly 1.5 million annual procedures.

Simultaneously, innovation in biologic and bioabsorbable mesh materials is driving market momentum as surgeons aim to reduce chronic inflammatory responses associated with permanent synthetic implants. These advanced matrices are engineered to support natural tissue remodeling and minimize the risk of recurrence, addressing a critical need for high-risk patient groups. The commercial success of these hybrid scaffolds highlights a decisive shift toward anatomy-preserving materials. As reported by Fierce Biotech in December 2025, TELA Bio announced full-year 2024 revenue of $69.3 million, representing a 19% increase attributed to the demand for its OviTex reinforced biologic mesh portfolio.

Market Challenge

The ongoing scrutiny regarding post-operative complications and legal disputes associated with synthetic mesh implants presents a significant barrier to entry and expansion in the Global Hernia Repair Devices Market. Manufacturers are compelled to meet rigorous clinical evidence standards to mitigate liability risks, a requirement that drastically inflates research and development costs while extending approval timelines. This challenging regulatory environment forces companies to divert capital toward legal defense and compliance rather than innovation, resulting in a deceleration in the commercialization of next-generation herniorrhaphy devices.

These regulatory pressures directly reduce regional market attractiveness and product availability. Data from MedTech Europe in 2024 indicates that the percentage of large medical device manufacturers choosing the European Union as their initial launch geography fell by 33 percent due to the complexities of meeting heightened safety and performance requirements. This trend illustrates how regulatory stringency, driven by safety concerns, effectively limits the volume of new products reaching established healthcare systems. By stifling the introduction of advanced technologies, the market experiences slower revenue turnover and reduced procedural adoption rates for novel repair materials.

Market Trends

The migration of hernia repair procedures to Ambulatory Surgical Centers (ASCs) is fundamentally changing the site-of-care landscape for abdominal wall reconstruction. Payors and healthcare systems are actively incentivizing the shift of intermediate-acuity surgeries, such as inguinal and ventral hernia repairs, from hospital inpatient departments to outpatient facilities to enhance cost-efficiency and procedural turnover. This structural transition is supported by substantial revenue growth in dedicated surgical divisions of major health systems. For example, ASC News reported in February 2025 that Tenet Healthcare's United Surgical Partners International (USPI) division achieved full-year 2024 net operating revenues of $4.5 billion, a 15.4% increase driven largely by the volume shift of high-acuity cases to ambulatory settings.

Concurrently, there is a surging demand for biologic and biosynthetic mesh implants, particularly those utilizing advanced polymer technologies like poly-4-hydroxybutyrate (P4HB). Unlike traditional biologics often reserved for complex reconstructions in high-risk patients, newer biosynthetic platforms are entering the market for routine defects, such as umbilical hernias, offering resorbable scaffolds that provide temporary strength without leaving permanent foreign material. This adoption is evidenced by the commercial scaling of next-generation absorbable portfolios. As noted by Xtalks in April 2025, Becton, Dickinson and Company launched a new P4HB patch and announced that its bioabsorbable Phasix Mesh portfolio has now surpassed 385,000 implants globally.

Key Market Players

• Medtronic Plc.
• Ethicon Inc.
• Beckton Dickinson & Co,
• Atrium
• W. L. Gore & Associates, Inc.
• LifeCell International Pvt. Ltd.
• B. Braun SE
• Baxter International Inc.
• Cook Medical Inc
• Herniamesh S.r.l.

Report Scope

In this report, the Global Hernia Repair Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hernia Repair Devices Market, By Product Type

• Hernia Mesh
• Hernia Fixation Devices

Hernia Repair Devices Market, By Procedure Type

• Open Surgery
• Laparoscopic Surgery

Hernia Repair Devices Market, By Surgery Type

• Inguinal Hernia
• Umbilical Hernia
• Incisional Hernia
• Femoral Hernia
• Others

Hernia Repair Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hernia Repair Devices Market.

Available Customizations:

Global Hernia Repair Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hernia Repair Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Hernia Mesh, Hernia Fixation Devices)
  • 5.2.2. By Procedure Type (Open Surgery, Laparoscopic Surgery)
  • 5.2.3. By Surgery Type (Inguinal Hernia, Umbilical Hernia, Incisional Hernia, Femoral Hernia, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Hernia Repair Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Procedure Type
  • 6.2.3. By Surgery Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hernia Repair Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Procedure Type
      • 6.3.1.2.3. By Surgery Type
  • 6.3.2. Canada Hernia Repair Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Procedure Type
      • 6.3.2.2.3. By Surgery Type
  • 6.3.3. Mexico Hernia Repair Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Procedure Type
      • 6.3.3.2.3. By Surgery Type

7. Europe Hernia Repair Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Procedure Type
  • 7.2.3. By Surgery Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hernia Repair Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Procedure Type
      • 7.3.1.2.3. By Surgery Type
  • 7.3.2. France Hernia Repair Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Procedure Type
      • 7.3.2.2.3. By Surgery Type
  • 7.3.3. United Kingdom Hernia Repair Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Procedure Type
      • 7.3.3.2.3. By Surgery Type
  • 7.3.4. Italy Hernia Repair Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Procedure Type
      • 7.3.4.2.3. By Surgery Type
  • 7.3.5. Spain Hernia Repair Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Procedure Type
      • 7.3.5.2.3. By Surgery Type

8. Asia Pacific Hernia Repair Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Procedure Type
  • 8.2.3. By Surgery Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hernia Repair Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Procedure Type
      • 8.3.1.2.3. By Surgery Type
  • 8.3.2. India Hernia Repair Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Procedure Type
      • 8.3.2.2.3. By Surgery Type
  • 8.3.3. Japan Hernia Repair Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Procedure Type
      • 8.3.3.2.3. By Surgery Type
  • 8.3.4. South Korea Hernia Repair Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Procedure Type
      • 8.3.4.2.3. By Surgery Type
  • 8.3.5. Australia Hernia Repair Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Procedure Type
      • 8.3.5.2.3. By Surgery Type

9. Middle East & Africa Hernia Repair Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Procedure Type
  • 9.2.3. By Surgery Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hernia Repair Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Procedure Type
      • 9.3.1.2.3. By Surgery Type
  • 9.3.2. UAE Hernia Repair Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Procedure Type
      • 9.3.2.2.3. By Surgery Type
  • 9.3.3. South Africa Hernia Repair Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Procedure Type
      • 9.3.3.2.3. By Surgery Type

10. South America Hernia Repair Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Procedure Type
  • 10.2.3. By Surgery Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hernia Repair Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Procedure Type
      • 10.3.1.2.3. By Surgery Type
  • 10.3.2. Colombia Hernia Repair Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Procedure Type
      • 10.3.2.2.3. By Surgery Type
  • 10.3.3. Argentina Hernia Repair Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Procedure Type
      • 10.3.3.2.3. By Surgery Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hernia Repair Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Ethicon Inc.
• 15.3. Beckton Dickinson & Co,
• 15.4. Atrium
• 15.5. W. L. Gore & Associates, Inc.
• 15.6. LifeCell International Pvt. Ltd.
• 15.7. B. Braun SE
• 15.8. Baxter International Inc.
• 15.9. Cook Medical Inc
• 15.10. Herniamesh S.r.l.

16. Strategic Recommendations

17. About Us & Disclaimer